-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
-
CHITOSE Group Forms Capital and Business Alliance with TOPPAN Holdings
-
Media / Editorial
2024.10.04
CHITOSE AI-Powered Bioproduction Management System Featured in Focus NEDO No. 92
-
CHITOSE Group Announces Capital Raising of JPY 500 Million from NSK ltd. and Conclusion of Business Alliance Agreement
-
Media / Editorial
2024.07.31
Research Paper Published on CHO-MK: Novel Host Cell Line for Biopharmaceutical Manufacturing
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
